Breaking News

CROnos Appoints Scientific VP

April 3, 2014

Engelhardt brings 20 years of experience

Dr. Nina Engelhardt has been appointed vice president of Scientific Innovation at CROnos Clinical Consulting. Dr. Engelhardt has more than 20 years of experience with trial methodology and clinical assessment aimed at increasing the success rate of placebo-controlled CNS trials.
Prior to joining the company, Dr. Engelhardt served as senior clinical trainer and research scientist for MedAvante and senior therapeutic area associate for new antidepressants at Eli Lilly. She has also served as a clinical research associate in the division of Clinical Psychopharmacology, at Tufts-New England Medical Center.
"Nina is an exciting addition to our clinical team.  We look forward to tapping into her expertise to deliver an improved product to our customers," said Guillermo Di Clemente, president and founder, CROnos. "Her diverse experience provides an outstanding view of our market and its current and future innovations."
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision